Table 1 Clinical and biochemical features in study subjects

No. of subjects

122

120

–

Gender, M/F

40/82

35/85

0.580

Age (years)

41.89 ± 9.64

40.22 ± 10.88

0.208

BMI (kg/m²)

23.60 ± 2.24

21.24 ± 2.91

< 0.001

WC (cm)

81 ± 8

76 ± 7

< 0.001

SBP (mmHg)

119 ± 11

121 ± 10

0.174

DBP (mmHg)

73 ± 7

77 ± 8

< 0.001

TC (mM)

4.76 ± 1.00

3.79 ± 0.85

< 0.001

TG (mM)^£

1.38 (0.99,1.91)

1.07 (0.86,1.37)

< 0.001

LDLC (mM)

2.78 ± 0.83

1.62 ± 0.55

< 0.001

HDLC (mM)

1.46 ± 0.36

1.53 ± 0.40

0.194

ALT (IU/L)^£

21 (14,29)

25 (17,38)

< 0.001

AST (IU/L)^£

23 (18,29)

24 (19,31)

0.081

TBIL (μmol/l)^£

11.4 (8.2,15.3)

13.6 (10.3,18.2)

0.002

DBIL (μmol/l)^£

3.3 (2.5,4.5)

4.6 (3.4,6.2)

< 0.001

FPG (mM)

5.13 ± 0.54

5.21 ± 0.61

0.293

FT3 (pmol/L)£

4.64 (4.01,5.63)

13.72 (9.71,19.18)

< 0.001

FT4 (pmol/L)£

16.36 (14.30,18.43)

39.00 (29.46,54.32)

< 0.001

TSH (uIU/ml)

2.560 (1.558,3.390)

0.008 (0.004,0.049)

< 0.001

TRAb (IU/ml)^£

3.10 (0.70,5.58)

29.88 (20.66,63.68)

< 0.001

ZAG (mg/L)

47.81 ± 12.90

66.51 ± 13.53

< 0.001